299 related articles for article (PubMed ID: 30706137)
1. Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients.
Mauch RM; Rossi CL; Nolasco da Silva MT; Bianchi Aiello T; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
Med Microbiol Immunol; 2019 Apr; 208(2):205-213. PubMed ID: 30706137
[TBL] [Abstract][Full Text] [Related]
2. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.
Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis.
Pedersen SS; Møller H; Espersen F; Sørensen CH; Jensen T; Høiby N
APMIS; 1992 Apr; 100(4):326-34. PubMed ID: 1581041
[TBL] [Abstract][Full Text] [Related]
4. A specific serum IgA antibody discriminates pneumonia from colonization state in patients with Pseudomonas aeruginosa in sputum culture.
Yamashita M; Hida Y; Sugimoto H; Takahashi N; Kimura H; Nakatomi Y; Yoshida H; Ishizaki T
J Microbiol Methods; 2010 Sep; 82(3):198-204. PubMed ID: 20538018
[TBL] [Abstract][Full Text] [Related]
5. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
Aanæs K
J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
[TBL] [Abstract][Full Text] [Related]
6. Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis.
Brett MM; Ghoneim AT; Littlewood JM
Arch Dis Child; 1990 Mar; 65(3):259-63. PubMed ID: 2110441
[TBL] [Abstract][Full Text] [Related]
7. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity.
Schaad UB; Lang AB; Wedgwood J; Buehlamnn U; Fuerer E
Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907
[TBL] [Abstract][Full Text] [Related]
8. Role of cations and IgA in saliva-mediated aggregation of Pseudomonas aeruginosa in cystic fibrosis patients.
Armstrong EA; Ziola B; Habbick BF; Komiyama K
J Oral Pathol Med; 1993 May; 22(5):207-13. PubMed ID: 8315600
[TBL] [Abstract][Full Text] [Related]
9. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM
JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125
[TBL] [Abstract][Full Text] [Related]
10. Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.
Tiddens HA; De Boeck K; Clancy JP; Fayon M; H G M A; Bresnik M; Derchak A; Lewis SA; Oermann CM;
J Cyst Fibros; 2015 Jan; 14(1):111-9. PubMed ID: 25091537
[TBL] [Abstract][Full Text] [Related]
11. Significance of immunologic factors in cystic fibrosis.
Przyklenk B; Bauernfeind A
Scand J Gastroenterol Suppl; 1988; 143():103-9. PubMed ID: 2455329
[TBL] [Abstract][Full Text] [Related]
12. An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis.
Brett MM; Ghoneim AT; Littlewood JM
J Clin Pathol; 1988 Oct; 41(10):1130-4. PubMed ID: 3142934
[TBL] [Abstract][Full Text] [Related]
13. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
[TBL] [Abstract][Full Text] [Related]
14. Anti-PcrV titers in non-cystic fibrosis patients with Pseudomonas aeruginosa respiratory tract infection.
Nagaoka K; Yamashita Y; Kimura H; Kimura H; Suzuki M; Fukumoto T; Hayasaka K; Yoshida M; Hara T; Maki H; Ohkawa T; Konno S
Int J Infect Dis; 2019 Oct; 87():54-59. PubMed ID: 31419482
[TBL] [Abstract][Full Text] [Related]
15. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.
Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG
Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432
[TBL] [Abstract][Full Text] [Related]
16. Distribution of antibodies to selected antigens of Pseudomonas aeruginosa in children and young adults with cystic fibrosis.
Gaweł J; Pogorzelski A; Działek-Smętek E; Sochań B; Ligarska R; Lącka M; Mazurek H
Pneumonol Alergol Pol; 2014; 82(4):336-41. PubMed ID: 24964236
[TBL] [Abstract][Full Text] [Related]
17. Paranasal sinus pathogens in children with cystic fibrosis: do they relate to lower respiratory tract pathogens and is eradication successful?
Wilson P; Lambert C; Carr SB; Pao C
J Cyst Fibros; 2014 Jul; 13(4):449-54. PubMed ID: 24713592
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.
Pedersen SS; Espersen F; Høiby N; Jensen T
J Clin Microbiol; 1990 Apr; 28(4):747-55. PubMed ID: 2110181
[TBL] [Abstract][Full Text] [Related]
19. Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study.
Brett MM; Ghoneim AT; Littlewood JM
J Clin Microbiol; 1988 Aug; 26(8):1565-70. PubMed ID: 3139707
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening.
Hayes D; Farrell PM; Li Z; West SE
Pediatr Pulmonol; 2010 Jan; 45(1):55-61. PubMed ID: 20025049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]